Tag: Vitamin k antagonist

While most commonly known for its anticoagulant properties, warfarin can, in rare cases, trigger the devastating condition of calciphylaxis. The mechanism behind this serious adverse effect is linked to the medication's interaction with vitamin K, which impacts not only clotting factors but also proteins that prevent vascular calcification.

Phenprocoumon, a vitamin K antagonist, is a standard oral anticoagulant used widely in many European countries. Given its different international usage and branding, many people wonder what is another name for Phenprocoumon and why identifying it correctly is crucial for patient safety and effective treatment.

Phenprocoumon is a medication used in approximately 1 million patients in Germany alone for the prevention of dangerous blood clots [1.6.5]. So, **what is the classification of Phenprocoumon?** It is a long-acting oral anticoagulant classified as a vitamin K antagonist and a coumarin derivative [1.2.2, 1.2.5].

Introduced in the early 1950s, the medication **Phenindione** belongs to a class of drugs called oral anticoagulants, specifically known as Vitamin K antagonists (VKAs). Although once used for preventing blood clots, it is now largely replaced by safer alternatives due to a higher risk of adverse effects.